Literature DB >> 24378255

Cognitive outcomes after psychotherapeutic interventions for major depression in older adults with executive dysfunction.

R Scott Mackin1, J Craig Nelson2, Kevin Delucchi2, Patrick Raue3, Amy Byers4, Deborah Barnes4, Derek D Satre5, Kristine Yaffe4, George S Alexopoulos3, Patricia A Arean2.   

Abstract

OBJECTIVE: The purpose of this study was to determine the impact of psychotherapy on cognitive functioning in older adults with late-life depression (LLD) and executive dysfunction.
METHODS: Two hundred twenty-one adults aged 60 years and older participated in a randomized clinical trial comparing the efficacy of Problem Solving Therapy (PST) and Supportive Therapy (ST) for LLD. Cognitive performance on seven tests of executive functioning, verbal learning, and memory was evaluated at baseline, after 12 weeks of treatment, and at 24 weeks after the completion of treatment.
RESULTS: Performance on a measure of executive functioning with a significant information processing speed component (Stroop Color and Word Test) improved after treatment, F (1, 312) = 8.50, p = 0.002, and improved performance was associated with a reduction in depressive symptoms but not treatment type. Performance on other measures of executive functioning, verbal learning, and memory did not change significantly after 12 weeks of psychotherapy treatment.
CONCLUSION: Our results suggest that improvements in cognitive functioning after psychotherapy treatment for depression in older adults with executive dysfunction are likely focal and not distributed across all cognitive domains. Although previous analyses reported that PST was superior to ST in the treatment of depression, this analysis indicated no difference between the two treatments with regard to improvements in cognitive functioning. Published by Elsevier Inc.

Entities:  

Keywords:  Cognitive functioning; executive dysfunction; information processing speed; late-life depression; learning; memory; mild cognitive impairment; psychotherapy

Mesh:

Year:  2013        PMID: 24378255      PMCID: PMC4108572          DOI: 10.1016/j.jagp.2013.11.002

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  36 in total

1.  Support for the vascular depression hypothesis in late-life depression: results of a 2-site, prospective, antidepressant treatment trial.

Authors:  Yvette I Sheline; Carl F Pieper; Deanna M Barch; Kathleen Welsh-Bohmer; Kathleen Welsh-Boehmer; Robert C McKinstry; James R MacFall; Gina D'Angelo; Keith S Garcia; Kenneth Gersing; Consuelo Wilkins; Warren Taylor; David C Steffens; Ranga R Krishnan; P Murali Doraiswamy
Journal:  Arch Gen Psychiatry       Date:  2010-03

2.  The prevalence of depression in Alzheimer's disease and vascular dementia in a population sample.

Authors:  S C Newman
Journal:  J Affect Disord       Date:  1999 Jan-Mar       Impact factor: 4.839

3.  Social problem-solving therapy for unipolar depression: an initial dismantling investigation.

Authors:  A M Nezu; M G Perri
Journal:  J Consult Clin Psychol       Date:  1989-06

4.  Depressive symptoms and the cost of health services in HMO patients aged 65 years and older. A 4-year prospective study.

Authors:  J Unützer; D L Patrick; G Simon; D Grembowski; E Walker; C Rutter; W Katon
Journal:  JAMA       Date:  1997-05-28       Impact factor: 56.272

5.  Executive dysfunction and long-term outcomes of geriatric depression.

Authors:  G S Alexopoulos; B S Meyers; R C Young; B Kalayam; T Kakuma; M Gabrielle; J A Sirey; J Hull
Journal:  Arch Gen Psychiatry       Date:  2000-03

6.  Comparison of sertraline and nortriptyline in the treatment of major depressive disorder in late life.

Authors:  W Bondareff; M Alpert; A J Friedhoff; E M Richter; C M Clary; E Batzar
Journal:  Am J Psychiatry       Date:  2000-05       Impact factor: 18.112

7.  The effect of cognitive impairment on mental healthcare costs for individuals with severe psychiatric illness.

Authors:  R Scott Mackin; Kevin L Delucchi; Robert W Bennett; Patricia A Areán
Journal:  Am J Geriatr Psychiatry       Date:  2011-02       Impact factor: 4.105

8.  Problem-solving therapy and supportive therapy in older adults with major depression and executive dysfunction.

Authors:  Patricia A Areán; Patrick Raue; R Scott Mackin; Dora Kanellopoulos; Charles McCulloch; George S Alexopoulos
Journal:  Am J Psychiatry       Date:  2010-06-01       Impact factor: 18.112

9.  The nature and determinants of neuropsychological functioning in late-life depression.

Authors:  Meryl A Butters; Ellen M Whyte; Robert D Nebes; Amy E Begley; Mary Amanda Dew; Benoit H Mulsant; Michelle D Zmuda; Rishi Bhalla; Carolyn Cidis Meltzer; Bruce G Pollock; Charles F Reynolds; James T Becker
Journal:  Arch Gen Psychiatry       Date:  2004-06

10.  Comparative effectiveness of social problem-solving therapy and reminiscence therapy as treatments for depression in older adults.

Authors:  P A Arean; M G Perri; A M Nezu; R L Schein; F Christopher; T X Joseph
Journal:  J Consult Clin Psychol       Date:  1993-12
View more
  18 in total

1.  Longitudinal Cognitive Outcomes of Clinical Phenotypes of Late-Life Depression.

Authors:  Meghan Riddle; Guy G Potter; Douglas R McQuoid; David C Steffens; John L Beyer; Warren D Taylor
Journal:  Am J Geriatr Psychiatry       Date:  2017-03-28       Impact factor: 4.105

Review 2.  Promoting Successful Cognitive Aging: A Ten-Year Update.

Authors:  Taylor J Krivanek; Seth A Gale; Brittany M McFeeley; Casey M Nicastri; Kirk R Daffner
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

Review 3.  Posttraumatic Stress Disorder in Older Adults: A Conceptual Review.

Authors:  Anica Pless Kaiser; Joan M Cook; Debra M Glick; Jennifer Moye
Journal:  Clin Gerontol       Date:  2018-11-13       Impact factor: 2.619

4.  Depression, cognitive, and functional outcomes of Problem Adaptation Therapy (PATH) in older adults with major depression and mild cognitive deficits.

Authors:  Dora Kanellopoulos; Paul Rosenberg; Lisa D Ravdin; Dalynah Maldonado; Nimra Jamil; Crystal Quinn; Dimitris N Kiosses
Journal:  Int Psychogeriatr       Date:  2020-01-08       Impact factor: 3.878

5.  Executive Dysfunction Predicts Treatment Response to Neuroplasticity-Based Computerized Cognitive Remediation (nCCR-GD) in Elderly Patients with Major Depression.

Authors:  Sarah Shizuko Morimoto; Faith M Gunning; Bruce E Wexler; Willie Hu; Irena Ilieva; Jiacheng Liu; Juliana Nitis; George S Alexopoulos
Journal:  Am J Geriatr Psychiatry       Date:  2016-07-01       Impact factor: 4.105

6.  Does cognition predict treatment response and remission in psychotherapy for late-life depression?

Authors:  Sherry A Beaudreau; Tiffany Rideaux; Ruth O'Hara; Patricia Arean
Journal:  Am J Geriatr Psychiatry       Date:  2014-09-21       Impact factor: 4.105

7.  Psychosocial Treatment Options for Major Depressive Disorder in Older Adults.

Authors:  Brenna N Renn; Patricia A Areán
Journal:  Curr Treat Options Psychiatry       Date:  2017-02-08

8.  FMRI activation during executive function predicts response to cognitive behavioral therapy in older, depressed adults.

Authors:  Dolores Gallagher Thompson; Shelli R Kesler; Keith Sudheimer; Kala Mehendra Mehta; Larry W Thompson; Renee M Marquett; Jason M Holland; Robert Reiser; Natalie Rasgon; Alan Schatzberg; Ruth M O'Hara
Journal:  Am J Geriatr Psychiatry       Date:  2014-02-18       Impact factor: 4.105

9.  Problem-Solving Therapy Reduces Suicidal Ideation In Depressed Older Adults with Executive Dysfunction.

Authors:  Kristen A Gustavson; George S Alexopoulos; Grace C Niu; Charles McCulloch; Tanya Meade; Patricia A Areán
Journal:  Am J Geriatr Psychiatry       Date:  2015-07-30       Impact factor: 4.105

10.  Prevalence of perceived cognitive dysfunction in survivors of a wide range of cancers: results from the 2010 LIVESTRONG survey.

Authors:  John E Schmidt; Ellen Beckjord; Dana H Bovbjerg; Carissa A Low; Donna M Posluszny; Amy E Lowery; Mary Amanda Dew; Stephanie Nutt; Sarah R Arvey; Ruth Rechis
Journal:  J Cancer Surviv       Date:  2015-08-04       Impact factor: 4.442

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.